Kazutomo Sawai | Health Professions | Best Researcher Award

Dr. Kazutomo Sawai | Health Professions | Best Researcher Award

President from Hanshin Medical Co-op Daisan Clinic, Japan

Dr. Kazutomo Sawai is a distinguished Japanese physician-researcher specializing in nephrology and Kampo (traditional Japanese) medicine. He has made outstanding contributions to the understanding of glomerular regeneration, diabetic nephropathy, and molecular markers of kidney disease. With over two decades of clinical and research experience, Dr. Sawai combines modern medical science with traditional therapeutic approaches to address complex renal pathologies. His professional journey encompasses high-level academic training, fellowships at prominent institutions, and leadership roles within clinical practice and education. Since 2010, he has served as President of Daisan Clinic in Amagasaki, Hyogo, Japan, where he also champions patient education and community healthcare. Dr. Sawai’s international presence is marked by presentations at global nephrology congresses, highlighting his pivotal research on Connexin43 and Cyr61 expression in diabetic nephropathy and glomerulonephritis. His clinical insights are further enriched through his integration of Kampo medicine, reflected in his successful management of chronic cases through traditional prescriptions. A fellow of multiple Japanese medical societies, he has received notable honors for his scientific achievements. Dr. Sawai remains a committed clinician, educator, and researcher, dedicated to translational nephrology, patient-centered care, and the advancement of integrative medicine practices.

Professional Profile

Education

Dr. Kazutomo Sawai pursued his foundational medical education at the esteemed Kyoto University School of Medicine, obtaining his M.D. in 1995. Demonstrating an early interest in renal pathophysiology, he continued his academic journey by earning a Ph.D. in Renal Physiology from Kyoto University Graduate School of Medicine in 2004. His doctoral work focused on glomerular disease mechanisms and the role of angiogenic and podocyte-specific factors in kidney regeneration. Dr. Sawai’s postgraduate training included a comprehensive residency in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital between 1995 and 1997. He later undertook specialized fellowships in nephrology and dialysis therapy from 1998 to 2001 at both Saiseikai Nakatsu and Kyoto University Hospitals. Expanding his scope beyond conventional medicine, Dr. Sawai completed dual fellowships in Kampo medicine between 2015 and 2018 at Midorinokaze Clinic and Rakuwakai Otowa Hospital. This diverse academic and clinical training underpins his multidisciplinary approach to kidney care, integrating Western biomedical science with traditional Japanese therapeutics. Dr. Sawai’s strong academic background has laid a robust foundation for his research contributions and clinical leadership, positioning him as a key figure in the evolution of nephrology and holistic patient care in Japan.

Professional Experience

Dr. Sawai has cultivated an illustrious professional career marked by significant academic, clinical, and administrative roles. His early medical career began with residencies in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital from 1995 to 1997. He then specialized in nephrology and dialysis therapy during fellowships at these institutions through 2001. Dr. Sawai’s academic appointments include a role as Project Researcher in Internal Medicine at Kyoto University in 2004 and a notable tenure as Chief Researcher at the National Cardiovascular Center Research Institute in Osaka from 2004 to 2010. In 2010, he assumed the presidency of Daisan Clinic in Amagasaki, where he continues to practice, lead, and mentor. His responsibilities extend to community health, serving as Medical Director and Adviser for local home care services, and contributing as a committee member overseeing free and low-cost medical programs. He has also taught at Saiseikai Nakatsu Nursing School and Hanshin Cooperative Association Community College. With an integrated focus on internal medicine, nephrology, dialysis, and Kampo medicine, Dr. Sawai’s professional journey reflects a commitment to advancing holistic healthcare, clinical education, and community outreach.

Research Interest

Dr. Sawai’s research interests span the molecular, cellular, and clinical dimensions of nephrology. His work is particularly focused on the pathophysiology of glomerular diseases, including diabetic nephropathy, anti-GBM nephritis, and glomerulonephritis. He has extensively investigated the roles of podocyte-specific genes, such as Cyr61 (CCN1) and Connexin43, in renal injury and regeneration. These studies have led to insights into the mechanisms of podocyte dysfunction and the potential use of angiogenic and regenerative factors in predicting or improving renal outcomes. A pioneer in integrating traditional medicine into modern nephrology, Dr. Sawai has also explored the therapeutic applications of Kampo prescriptions in managing chronic symptoms such as dementia, hypertension, and neuropathic pain. His case studies highlight the efficacy of herbal formulations in complex clinical scenarios that often resist conventional treatment. His broader interest encompasses translational nephrology, where laboratory discoveries can inform clinical practice. With a comprehensive understanding of both biomedical science and traditional Japanese healing systems, Dr. Sawai’s research bridges disciplines to deliver patient-centered, evidence-based, and integrative kidney care. His continuous presence at national and international conferences further demonstrates his commitment to advancing nephrology and promoting the fusion of traditional and modern medical systems.

Research Skills

Dr. Sawai brings a sophisticated portfolio of research skills to the field of nephrology and integrative medicine. Trained in both clinical and bench research environments, he has demonstrated strong capabilities in experimental nephrology, molecular biology, and pathophysiological analysis. His core competencies include immunohistochemistry, gene expression profiling, and biomarker discovery, particularly focusing on proteins like Cyr61 and Connexin43 in renal pathology. His collaborative research has leveraged rodent models of glomerulonephritis and diabetic nephropathy to explore regeneration pathways in the kidney. Dr. Sawai’s ability to translate these findings into clinical insights distinguishes his work in translational medicine. Additionally, his skills extend to clinical trial design, retrospective case analysis, and Kampo prescription efficacy assessment, making him a rare blend of experimental and clinical researcher. He is also an experienced academic presenter and has delivered over 30 presentations at regional, national, and international conferences. His capacity for multidisciplinary collaboration, particularly in combining conventional nephrology with traditional Japanese Kampo medicine, reflects advanced integrative research skills. Through his leadership at Daisan Clinic, he continues to apply these skills in real-world settings, facilitating a seamless interface between research innovation and patient care.

Awards and Honors

Throughout his career, Dr. Kazutomo Sawai has received multiple accolades in recognition of his academic and research excellence. Among the earliest distinctions was the Miyake Memorial Award from Kyoto University Graduate School of Medicine in 2003, acknowledging his contributions to internal medicine and clinical science. In 2004, he was the recipient of the Tsujisaka Memorial Scholarship, awarded for scholarly promise and research potential in the field of renal physiology. The Young Researcher’s Award conferred at the 42nd Annual Meeting of the Japanese Society of Molecular Medicine in 2005 further highlighted his innovative work on glomerular regeneration. He also earned a Travel Grant from the American Society of Nephrology, which enabled him to present his research at international platforms and expand cross-border academic exchange. These honors not only affirm his impactful scientific work but also emphasize his contributions to the global discourse on nephrology. Dr. Sawai’s recognition by both Japanese and international institutions reflects the high quality and significance of his research. His continued academic output and interdisciplinary approach ensure that he remains at the forefront of innovation in renal medicine and integrative therapies.

Conclusion

Dr. Kazutomo Sawai stands out as a clinician-researcher of exceptional caliber, whose multifaceted career bridges the realms of nephrology, internal medicine, and Kampo therapeutics. His academic foundation at Kyoto University, combined with specialized fellowships in nephrology and traditional medicine, has shaped a unique professional identity that is both modern and rooted in tradition. As President of Daisan Clinic, he has made significant contributions to clinical nephrology while also enhancing community health services and medical education. Dr. Sawai’s research has had a profound impact on the understanding of podocyte biology, glomerular regeneration, and diabetic nephropathy, with practical applications for improving patient outcomes. His pioneering integration of Kampo medicine into nephrology offers novel approaches to managing chronic, treatment-resistant conditions. Despite a lack of editorial roles, his active participation in national and international scientific forums and multiple honors confirm his standing in the field. Dr. Sawai exemplifies dedication to science, education, and compassionate patient care, making him an ideal candidate for prestigious recognition such as the Best Researcher Award. His work continues to inspire the next generation of healthcare professionals and researchers in Japan and beyond.

Publications Top Notes

1. Traditional remedy-induced Chinese herbs nephropathy showing rapid deterioration of renal function

  • Year: 1997

  • Authors: Tanaka A, Nishida R, Sawai K, Nagae T, Shinkai S, Ishikawa M, Maeda K, Murata M, Seta K, Okuda J, Yoshida T, Sugawara A, Kuwahara T

  • Journal: Nihon Jinzo Gakkai Shi

2. Human parvovirus B19 infection resembling systemic lupus erythematosus

  • Year: 1998

  • Authors: Tanaka A, Sugawara A, Sawai K, Kuwahara T

  • Journal: Intern Med

3. Concealed hypothyroidism in patients with myeloperoxidase antineutrophil cytoplasmic autoantibodies (MPO-ANCA) positive renal disease

  • Year: 1999

  • Authors: Tanaka A, Maeda K, Sawai K, Okuda J, Sugawara A, Kuwahara T

  • Journal: Clinical Nephrology

4. Intraglomerular metastasis from pancreatic cancer

  • Year: 2001

  • Authors: Yokoi H, Nakata M, Sawai K, Yoshida T, Koshikawa M, Joyama S, Tanaka A, Goto M, Ueda S, Senzaki H, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

5. C4d and C4bp deposition along the glomerular capillary walls in a patient with preeclampsia

  • Year: 2001

  • Authors: Joyama S, Yoshida T, Koshikawa M, Sawai K, Yokoi H, Tanaka A, Gotoh M, Ueda S, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

6. Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis

  • Year: 2003

  • Authors: Sawai K, Mori K, Mukoyama M, Sugawara A, Suganami T, Koshikawa M, Yahata K, Makino H, Nagae T, Fujinaga Y, Yokoi H, Yoshioka T, Yoshimoto A, Tanaka I, Nakao K

  • Journal: Journal of the American Society of Nephrology

7. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis

  • Year: 2004

  • Authors: Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa M, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

8. Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy

  • Year: 2005

  • Authors: Suganami T, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Sawai K, Hidaka S, Ebihara K, Tanaka T, Sugawara A, Kawachi H, Vinson C, Ogawa Y, Nakao K

  • Journal: FASEB Journal

9. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury

  • Year: 2005

  • Authors: Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J

  • Journal: Journal of Clinical Investigation

10. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome

  • Year: 2005

  • Authors: Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

Seyed Hassan Tonekaboni | Medicine and Dentistry | Outstanding Contribution Award

Dr. Seyed Hassan Tonekaboni | Medicine and Dentistry | Outstanding Contribution Award

Clinical Research Fellow from Shahid Beheshti Medical University, Iran

Dr. Seyed Hassan Tonekaboni is a distinguished Pediatric Neurologist and academic leader with over three decades of experience in clinical care, research, and medical education. He currently serves as a Clinical Research Fellow at the Autism Research Centre, Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada, under the supervision of Dr. Evdokia Anagnostou. Prior to this, he held the prestigious position of Full Professor in the Department of Pediatrics at Shahid Beheshti Medical University (SBMU) in Tehran, Iran, and was a senior staff pediatric neurologist at Mofid Children’s Hospital. His expertise lies in pediatric neurology, neurogenetics, epilepsy, and neurodevelopmental disorders. Dr. Tonekaboni has been instrumental in shaping child neurology services in Iran and has led numerous research initiatives addressing the diagnosis, treatment, and management of neurological conditions in children. His contributions extend to education, where he played key roles in postgraduate training and curriculum development. A respected voice in his field, he has served on national committees, editorial boards, and research centers, contributing significantly to pediatric neurology research in Iran and internationally. With a strong foundation in clinical practice and a growing international research portfolio, Dr. Tonekaboni is recognized for his enduring impact on child health and neurodevelopmental care.

Professional Profile

Education

Dr. Seyed Hassan Tonekaboni’s educational journey is both extensive and highly specialized, reflecting his deep commitment to pediatric neurology and medical genetics. He obtained his medical degree (MD) from Shahid Beheshti Medical University (SBMU), Tehran, in 1990. Following his general pediatric residency at the same institution, he pursued a subspecialty in Pediatric Neurology from 1996 to 1998, earning his national board certification in this field. To further enhance his expertise, Dr. Tonekaboni undertook a prestigious fellowship in Medical Genetics (AFSA: Attestation de Formation Spécialisée Approfondie) at Pierre and Marie Curie University and Pitié-Salpêtrière Hospital in Paris, France, from 2003 to 2004. His postgraduate training includes clinical research fellowships and observerships in Canada, including at the SickKids Hospital and the Autism Research Centre at Holland Bloorview in Toronto. These programs focused on neurogenetics, neuromuscular disorders, and autism spectrum conditions, broadening his clinical and research skills in international settings. His comprehensive educational background—spanning Iran, France, and Canada—has allowed him to integrate global best practices with regional expertise. This diverse academic foundation has greatly informed his approach to complex pediatric neurological disorders and has supported his leadership in clinical research and academic development in both national and international contexts.

Professional Experience

Dr. Seyed Hassan Tonekaboni has amassed a wealth of professional experience across clinical, academic, and research domains in pediatric neurology. His early career began at Mofid Children’s Hospital, where he served as a Staff Pediatrician and Clinician Educator from 1993 onward. Over the decades, he progressively held key academic roles at Shahid Beheshti Medical University (SBMU), becoming Assistant Professor in 2004, Associate Professor in 2005, and ultimately Full Professor by 2012. In these roles, he taught medical students and trained residents while managing pediatric neurology inpatient and outpatient services. From 2005 to 2017, he led the Medical Research Development Centre at Mofid Hospital, demonstrating his leadership in advancing research infrastructure. Dr. Tonekaboni has also held national positions, such as Vice Dean of Postgraduate Medical Education at SBMU, Vice President of the Iranian Neurogenetic Society, and a member of multiple Ministry of Health evaluation boards. His international engagement includes a research fellowship at Holland Bloorview Kids Rehabilitation Hospital in Canada, where he focuses on autism and neurodevelopmental research. His career reflects a deep commitment to integrating clinical excellence with research and policy development, making him a central figure in pediatric neurology in Iran and an emerging contributor in global pediatric neuroscience.

Research Interests

Dr. Seyed Hassan Tonekaboni’s research interests are grounded in pediatric neurology, with a particular emphasis on epilepsy, neurogenetic disorders, neurodevelopmental disabilities, and clinical pharmacology. His scholarly work spans several key domains, including the treatment and management of refractory epilepsy in children, neurocognitive outcomes of pharmacologic interventions, and the impact of dietary therapies like the ketogenic and Atkins diets on seizure control. Recently, his interests have expanded into neurodevelopmental disorders, including autism spectrum disorder (ASD), especially in the context of his ongoing clinical research fellowship in Canada. Dr. Tonekaboni is deeply invested in translational research that bridges clinical observations with practical therapeutic strategies. His studies often explore the efficacy and safety of antiepileptic drugs, diagnostic tools for genetic neurological conditions, and family-centered care approaches. He also investigates sociocultural factors influencing care delivery, such as maternal knowledge and attitudes toward childhood epilepsy. Through his involvement with national research centers and international academic institutions, Dr. Tonekaboni aims to contribute to evidence-based pediatric neurology practices. His multidisciplinary approach is informed by clinical observation, genetic science, and public health principles, making his work both scientifically valuable and socially relevant in improving outcomes for children with neurological disorders.

Research Skills

Dr. Tonekaboni possesses a comprehensive set of research skills that support his multidisciplinary approach to pediatric neurology. His clinical expertise enables him to design and conduct robust observational and interventional studies, particularly in epilepsy and neurodevelopmental disorders. He is well-versed in clinical trial design, including randomized controlled trials, as demonstrated in his investigations on the use of levetiracetam, buccal midazolam, and ketogenic diets for seizure control. His training in medical genetics has equipped him with skills in genetic diagnostics and the interpretation of genomic data, especially within the context of pediatric neurogenetic syndromes. Additionally, his experience at the Autism Research Centre and SickKids Hospital in Canada has expanded his competence in neurodevelopmental assessments and autism-related behavioral research. Dr. Tonekaboni is proficient in grant writing and has successfully secured research funding for multiple clinical studies. He also demonstrates strong academic writing and publication skills, contributing to peer-reviewed journals and serving on editorial boards. His leadership in research development at Mofid Children’s Hospital involved mentoring junior researchers and enhancing institutional research capacity. His methodological skills, combined with a collaborative mindset and clinical insight, make him adept at translating research findings into improved patient care strategies in pediatric neurology.

Awards and Honors

Over the course of his career, Dr. Seyed Hassan Tonekaboni has received numerous recognitions for his academic, clinical, and research achievements. Although specific named awards are not extensively listed, his honors are reflected in the prestigious positions he has held and the trust placed in him by national and institutional bodies. He has been appointed to critical national committees in Iran, including the Iranian National Board of Pediatric Neurology, the National Council of Neurology, and the Medical Graduate Evaluation Committee under the Ministry of Health. His election as Vice Dean of Postgraduate Medical Education and Head of the Research Development Centre at SBMU indicates high institutional recognition. Moreover, his selection as a fellow at internationally respected institutions—such as the Autism Research Centre in Canada and Pitié-Salpêtrière Hospital in France—reflects global recognition of his expertise and potential. He has also served as Chief Editor and Editorial Board Member for various scientific journals, such as the Iranian Journal of Child Neurology, confirming his scholarly influence. These appointments and invitations to contribute to academia, clinical service, and research infrastructure development are strong indicators of his outstanding contributions to pediatric neurology both nationally and internationally.

Conclusion

Dr. Seyed Hassan Tonekaboni is an accomplished pediatric neurologist and academic whose impact spans decades of clinical innovation, research leadership, and educational mentorship. His career reflects a seamless integration of clinical excellence and scholarly productivity, particularly in pediatric epilepsy, neurogenetics, and neurodevelopmental disorders. With a robust academic foundation and international collaborations in France and Canada, he has developed a global perspective on pediatric neurological care. Dr. Tonekaboni’s leadership roles in medical education, research administration, and national healthcare policy underscore his broad influence and commitment to advancing child health services in Iran and beyond. While his research visibility could be further amplified through increased high-impact international publications and global grant acquisition, his current portfolio demonstrates a substantial and meaningful contribution to medical science. His multidisciplinary approach, spanning clinical trials, genetics, education, and autism research, reflects his adaptability and dedication to addressing evolving challenges in pediatric neurology. In conclusion, Dr. Tonekaboni exemplifies the qualities of a seasoned clinician-scientist whose work continues to shape both academic scholarship and patient care. He is a strong candidate for recognition through awards that honor outstanding contributions to medical research and child neurological health.

Publications Top Notes

  • Title: Genetics of intellectual disability in consanguineous families
    Authors: H. Hu, K. Kahrizi, L. Musante, Z. Fattahi, R. Herwig, M. Hosseini, C. Oppitz, …
    Journal: Molecular Psychiatry, 24(7), 1027–1039
    Year: 2019
    Citations: 224

  • Title: Effect of inbreeding on intellectual disability revisited by trio sequencing
    Authors: K. Kahrizi, H. Hu, M. Hosseini, V.M. Kalscheuer, Z. Fattahi, M. Beheshtian, …
    Journal: Clinical Genetics, 95(1), 151–159
    Year: 2019
    Citations: 78

  • Title: Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity
    Journal: Neurogenetics, 7(3), 149–156
    Year: 2006
    Citations: 64

  • Title: GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): diagnosis and neuroimaging findings (an Iranian pediatric case series)
    Authors: P. Karimzadeh, N. Jafari, H.N. Biglari, S.J. Dari, F.A. Abadi, M.R. Alaee, …
    Journal: Iranian Journal of Child Neurology, 8(3), 55
    Year: 2014
    Citations: 61

  • Title: Efficacy of the Atkins diet as therapy for intractable epilepsy in children
    Authors: S.H. Tonekaboni, P. Mostaghimi, P. Mirmiran, A. Abbaskhanian, F.A. Gorji, …
    Journal: Archives of Iranian Medicine, 13(6), 492–497
    Year: 2010
    Citations: 60

  • Title: Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies
    Authors: Y. Nilipour, S. Nafissi, A.E. Tjust, G. Ravenscroft, H. Hossein Nejad Nedai, …
    Journal: European Journal of Neurology, 25(6), 841–847
    Year: 2018
    Citations: 50

  • Title: Neurocognitive effects of phenobarbital discontinuation in epileptic children
    Authors: S.H. Tonekaboni, N. Beyraghi, H.S. Tahbaz, S.A. Bahreynian, …
    Journal: Epilepsy & Behavior, 8(1), 145–148
    Year: 2006
    Citations: 48

  • Title: Knowledge, attitudes, and practices among mothers of children with epilepsy: a study in a teaching hospital
    Authors: A.A. Kolahi, M. Abbasi-Kangevari, P. Bakhshaei, F. Mahvelati-Shamsabadi, …
    Journal: Epilepsy & Behavior, 69, 147–152
    Year: 2017
    Citations: 47

  • Title: Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group
    Authors: MENA Pompe Working Group, F. Al Jasmi, M. Al Jumah, F. Alqarni, …
    Journal: BMC Neurology, 15, 1–17
    Year: 2015
    Citations: 47

  • Title: Bone mineral density in ambulatory children with epilepsy
    Authors: O. Yaghini, S.H. Tonekaboni, S.M. Amir Shahkarami, F. Ahmad Abadi, …
    Journal: The Indian Journal of Pediatrics, 82, 225–229
    Year: 2015
    Citations: 40

Mohamed Said Hassan | Health Professions | Best Researcher Award

Mr. Mohamed Said Hassan | Health Professions | Best Researcher Award

Researcher from Amoud University, Somalia

Mohamed Said Hassan is an accomplished public health and nutrition specialist with extensive experience in research, academia, and healthcare. His expertise spans multiple disciplines, including epidemiology, biochemistry, infectious diseases, and nutrition. He has served as a lecturer, researcher, and research supervisor in various institutions, including Amoud University, Horn International University, Gollis University, and Tima-ade University. With a passion for improving public health outcomes, he has conducted numerous studies on vaccination uptake, tuberculosis treatment adherence, hypertension management, and the prevalence of malaria. His ability to conduct community-based research, publish in peer-reviewed journals, and mentor students highlights his dedication to academic excellence and scientific advancement. In addition to his teaching and research experience, he has undergone professional training in food security, leadership in infection control, project management, and communication skills. His proficiency in multiple languages, including English, Somali, and Arabic, further enhances his ability to engage in international collaborations. Mohamed is a hardworking, analytical, and goal-oriented professional who strives to contribute to evidence-based public health policies. His dedication to research, education, and community health interventions makes him a valuable asset to both academic and healthcare institutions.

Professional Profile

Education

Mohamed Said Hassan has a strong academic background in public health and tropical infectious diseases. He is currently pursuing a Master of Science in Tropical Infectious Diseases at Haramaya University in Ethiopia, further advancing his expertise in epidemiology and disease prevention. Prior to this, he completed a Master of Public Health (MPH) at Amoud University in 2019 with a GPA of 3.2. His postgraduate studies equipped him with the skills necessary to analyze, design, and implement public health interventions. In 2009, he earned his Bachelor’s degree in Science from Amoud University, achieving an impressive GPA of 3.64. His undergraduate and postgraduate education have provided him with a solid foundation in research, data analysis, and evidence-based healthcare practices. Throughout his academic journey, he has continuously expanded his knowledge through professional training programs in food security, project management, and infectious disease control, offered by organizations such as WHO, UNICEF, and the African Academy. His educational background, combined with his research experience, has prepared him to address complex public health challenges, making him a well-rounded professional in the field of global health and epidemiology.

Professional Experience

Mohamed Said Hassan has accumulated extensive teaching, research, and public health experience across multiple institutions. Since March 2024, he has been working as a researcher at Amoud University, conducting community-based research and publishing scientific papers based on medical students’ theses. From 2018 to 2023, he served as a lecturer and research supervisor at Horn International University, where he trained students in research methodology, data collection, and analysis. His role also involved teaching courses in public health, nutrition, biochemistry, and organic chemistry. Additionally, he worked as a Public Health and Nutrition Instructor at the University of Buroa (2020-2021) and Gollis University (2021-2023), delivering lectures on epidemiology, communicable diseases, and nutrition intervention strategies. Currently, he is a Biology and Chemistry Instructor at Tima-ade University in Hargeisa, where he teaches courses such as botany, biochemistry, and organic chemistry. His ability to mentor students, design research guidelines, and conduct data-driven studies demonstrates his leadership in academia. His professional experience reflects his dedication to enhancing research capacity, improving public health education, and contributing to medical advancements.

Research Interest

Mohamed Said Hassan’s research interests focus on public health, epidemiology, infectious diseases, immunization, and nutrition science. His studies investigate the determinants of vaccination uptake, factors affecting tuberculosis treatment adherence, and the prevalence of malaria in developing countries. His work on exclusive breastfeeding practices, child nutrition, and hypertension management demonstrates his commitment to improving maternal and child health. Additionally, he is interested in exploring noncommunicable diseases, health system strengthening, and disease prevention strategies. His passion for evidence-based healthcare interventions is evident in his research on food security, infant and youth feeding programs, and communicable disease prevention. By collaborating with healthcare professionals and policymakers, he aims to bridge the gap between research findings and practical health solutions. His long-term goal is to contribute to global health initiatives, improve healthcare access in underserved communities, and develop strategies to enhance public health education. Through his diverse research portfolio, he strives to address critical health challenges and implement sustainable interventions that promote community well-being.

Research Skills

Mohamed Said Hassan possesses a strong set of research skills that allow him to conduct high-quality, data-driven studies. He is proficient in quantitative and qualitative research methodologies, data collection, and statistical analysis. His experience in survey design, questionnaire development, and field data collection has enabled him to conduct extensive community-based research. He is skilled in using statistical software for data analysis, ensuring accuracy and reliability in his findings. Additionally, he has expertise in literature reviews, systematic analysis, and report writing, which are essential for publishing in peer-reviewed journals. His ability to mentor students, develop research guidelines, and oversee thesis projects further highlights his leadership in academic research. Mohamed also has experience in grant writing and proposal development, which are crucial for securing research funding. His strong analytical and critical thinking skills allow him to interpret complex datasets and draw meaningful conclusions that contribute to public health policy and practice. His research skills make him a highly capable scientist committed to advancing knowledge in epidemiology, nutrition, and disease prevention.

Awards and Honors

While Mohamed Said Hassan has not received major research awards, his academic and professional contributions have earned him recognition in public health and academia. His work as a lecturer, researcher, and mentor has helped shape the next generation of public health professionals. His research publications in high-impact journals such as Plos One, BMC Primary Health Care, and Health Science Report highlight his academic excellence. His participation in training programs by WHO, UNICEF, and the African Academy reflects his commitment to professional development. While he has not received international research grants, his contributions to immunization, tuberculosis treatment, and child health research demonstrate his impact on public health advancement. To further strengthen his profile, he can apply for research fellowships, secure competitive grants, and collaborate with global institutions. His dedication to scientific research, mentorship, and healthcare improvement makes him a valuable candidate for future honors and awards.

Conclusion

Mohamed Said Hassan is a highly skilled researcher, academic, and public health specialist with a strong background in epidemiology, infectious diseases, and nutrition science. His extensive teaching experience, research publications, and professional training make him an asset to the field of public health research and education. His ability to mentor students, conduct community-based studies, and contribute to scientific literature highlights his dedication to improving healthcare systems and disease prevention strategies. While he has made significant contributions, expanding his work through international collaborations, securing research grants, and gaining global recognition will further strengthen his impact. His passion for evidence-based healthcare solutions and public health education makes him an ideal candidate for future research awards and leadership roles in the academic and public health sectors.

Publications Top Notes

  1. Title: Challenges for influencing exclusive breastfeeding practice among lactating mothers with infants aged 0–6 months in Borama District, Somaliland: A cross‐sectional study
    Authors: MS Hassan, MM Hossain
    Year: 2023
    Citations: 3

  2. Title: Craniopharyngioma in young female patient occurring after ovarian teratoma removal–A case report
    Authors: AI Said, M Abdulahi, MS Hassan, IH Ismail, AH Ahmed
    Year: 2025

  3. Title: Elbow interposition arthroplasty in a young adult: A case report
    Authors: YB Ibrahim, D Turan, M Kayse, M Abdulahi, MS Hassan, AI Said
    Year: 2025

  4. Title: Exclusive Breastfeeding Practices Among Somali Children: A Scoping Review
    Authors: MS Hassan, M Abdulahi, M Boqore
    Year: 2025

  5. Title: Sanitation Facilities in Somali Households: Evidence From a Multilevel Analysis of the 2020 Health and Demographic Survey
    Authors: MY Dahir, MS Hassan, MM Hossain
    Year: 2025

  6. Title: Factors Affecting Vaccine Cold Chain Management Practices in Public Health Facilities in Hargeisa, Somaliland
    Authors: HM Dahir, JO Osiri, MS Hassan, AH Korse, KA Ibrahim
    Year: 2025

  7. Title: Determinants of vaccination status among Somali children: evidence from a Countrywide cross-sectional survey
    Authors: MS Hassan, MM Hossain
    Year: 2024

  8. Title: Factors Affecting Utilization of Health Care Services among Nasahblood and Ayah 4 Internally Displaced Persons in Hargeisa Somaliland
    Authors: AH Korse, V Okoth, MS Hassan, HM Dahir, KA Ibrahim
    Year: 2024

  9. Title: Assessment of Knowledge, Attitude and Practice About Exclusive Breastfeeding Among Mothers Attending M. Mooge MCH Clinic, Hargeisa, Somaliland
    Authors: MI Ismail, MS Hassan, MA Mouse, HH Mohamed, HS Ahmed, NM Ali

Bassem Al Hariri | Health Professions | Best Researcher Award

Assist. Prof. Dr.  Bassem Al Hariri | Health Professions | Best Researcher Award

Assist. Prof. Dr. from Hamad Medical corporation, Qatar

Dr. Bassem Naif Altaleb Alhariri is a distinguished specialist in Internal Medicine and Pulmonary Diseases with extensive experience in clinical practice, medical education, and research. He is currently a Consultant in Internal Medicine & Pulmonology at Hamad Medical Corporation’s Hazm Mebaireek General Hospital in Qatar. Born in Syria on November 1, 1977, Dr. Alhariri has dedicated his career to providing high-quality medical care, mentoring young professionals, and contributing to research in his field. His expertise spans respiratory disorders, emergency medicine, and intensive care, along with a strong background in academic training and committee leadership. With multiple board certifications and international medical licensure, he has made significant contributions to internal medicine and pulmonology.

Professional Profile

Education

Dr. Alhariri earned his MD in General Medicine from Damascus University in 2004. He pursued a specialization in Internal Medicine, receiving his certification from the Syrian Ministry of Health in 2009. Furthering his expertise, he completed a specialization in Pulmonary Diseases in 2013. His postgraduate training included rigorous residency programs at Damascus’s top university hospitals, providing extensive exposure to various medical subspecialties. He holds board certifications in both Internal Medicine and Pulmonary Diseases from the Syrian Board, demonstrating his commitment to excellence in patient care and medical practice.

Professional Experience

Dr. Alhariri has amassed a wealth of experience across multiple medical institutions. He began his career in Syria, serving as a Senior Specialist in Internal Medicine at several government hospitals, later becoming the Head of Department at Izraa Hospital. From 2013 to 2016, he worked as a Consultant in Internal Medicine and Pulmonology, including humanitarian efforts with the International Medical Corps. Since 2017, he has been practicing in Qatar, first at a polyclinic and later at Hamad Medical Corporation. His expertise includes emergency care, intensive care unit (ICU) management, outpatient pulmonary services, and complex diagnostic procedures such as bronchoscopy, thoracoscopy, and lung biopsies.

Research Interests

Dr. Alhariri is deeply involved in medical research, focusing on respiratory disorders, critical care, and emerging treatments in pulmonology. His work includes studying innovative diagnostic techniques and therapeutic approaches for chronic respiratory diseases. As a member of Hamad Medical Corporation’s research committee, he actively contributes to clinical studies and the advancement of evidence-based medicine. His research interests align with improving patient outcomes through novel interventions, medical education strategies, and the integration of advanced diagnostic tools in pulmonary medicine.

Research Skills

Dr. Alhariri possesses strong research skills in clinical case analysis, medical data interpretation, and systematic reviews. His expertise extends to conducting hospital-based research, analyzing patient outcomes, and developing treatment protocols for respiratory conditions. As a reviewer for Clinical Case Reports Journal (Wiley), he critically evaluates medical research publications. His research methodology includes case-control studies, cohort analyses, and qualitative assessments of medical interventions. His ability to integrate clinical practice with research enhances his role as both a physician and an academic mentor.

Awards and Honors

Dr. Alhariri has been recognized for his contributions to medical education, clinical excellence, and research. He has served as an examiner for the Objective-Structured Clinical Exam (OSCE) at Qatar University and as a faculty member at Weill Cornell Medicine-Qatar. His leadership roles include membership in the Clinical Practice Guidelines (CPG) committee and education committees at Hamad Medical Corporation. His dedication to teaching has earned him appointments as a clinical lecturer at Qatar University and an assistant professor at Weill Cornell Medicine-Qatar. These honors reflect his commitment to fostering the next generation of medical professionals.

Conclusion

Dr. Bassem Naif Altaleb Alhariri is a highly accomplished medical professional with a deep passion for patient care, medical education, and research. His extensive experience in internal medicine and pulmonology, combined with his active role in academic training and clinical research, has positioned him as a key contributor to the field. With his unwavering dedication to medical excellence, Dr. Alhariri continues to impact healthcare in Qatar and beyond, shaping the future of respiratory medicine and mentoring aspiring physicians. His commitment to lifelong learning and innovation makes him a respected leader in his specialty.

Publications Top Notes

  1. Case of severe thrombocytopenia with recurrent extensive deep vein thrombosis due to antiphospholipid syndrome, management challenge

    • Authors: Bassem Al Hariri, Gaydaa Ali Ahmed Ali, Arwa Elfatih Mohamed Ali, Mohamed Elfatih MohamedAli, Feroz Jenner Poolakundan, Muhammad Sharif, Memon Noor Illahi
    • Year: 2025
  2. A rare case presentation of gastrointestinal stromal tumor (GIST) in a young adult patient

    • Authors: Bassem Al Hariri, Rawan S. Mohamed, Hadil Altaj Altrify Alsidig, Abdulqadir J. Nashwan, Muad Abdi Hassan
    • Year: 2024
  3. An adolescent presenting with Caroli syndrome associated with polycystic kidney disease: A case report

    • Authors: Bassem Al Hariri, Vajeeha Haider, Memon Noor Illahi, Muhammad Sharif, Abdulqadir J. Nashwan
    • Year: 2024
  4. An idiopathic severe macroglossia in a young adult patient: a rare case

    • Authors: Bassem Al Hariri, Muad A. Hassan, Muhammad Sharif, Rawan S. Mohamed, Hadil A. A. Alsidig, Hadil A. A. Alsiddig, Memon N. Illahi
    • Year: 2024
  5. Brucellosis an Unusual presentation as isolated septic mono-arthritis of the knee joint: A case report

    • Authors: Muad A. Hassan, F. Noor, A. Salehi, Bassem Al Hariri
    • Year: 2024
  6. Correction to “Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: a case report.”

    • Authors: Bassem Al Hariri, A. Alharafsheh, M. A. Hassan, A. J. Nashwan, M. G. Mohamedali, H. M. Abusriwil
    • Year: 2024
  7. Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial

    • Authors: K. Baagar, T. Alessa, M. Abu-Farha, J. Abubaker, H. Alhumaidi, J.A. Franco Ceruto, M.K. Hamad, A. Omrani, S. Abdelrahman, M. Zaka-Ul Haq, et al.
    • Year: 2024
  8. Periodic Paralysis: A Case Series with a Literature Review

    • Authors: Bassem Al Hariri, Muad A. Hassan, Muhammad Sharif, O. A. Alsakaji, Y. A. Hassan, M. K. Khalid
    • Year: 2024
  9. Streptococcus cristatus: An uncommon cause for a common hospital admission

    • Authors: U. Al-Anbagi, A. Salehi, G. J. Wilson, F. Noor, A. O. Mohamed, A. Haji, A. J. Nashwan, H. A. Nasir, Bassem A. Hariri
    • Year: 2024
  10. Unusual isolated splenic hydatid cyst: A case report

  • Authors: Bassem Al Hariri, Vajeeha Haider, Mamunul Islam, Abdalrahman Mohammed Mostafa, Ahmad Eid Nazzal Alharafsheh, Memon Noor Illahi
  • Year: 2024

 

Qingyuan Zhang | Medical Oncology | Best Researcher Award

Prof. Qingyuan Zhang | Medical Oncology | Best Researcher Award

Harbin Medical University Cancer Hospital, china

Dr. Qingyuan Zhang the Director of the Heilongjiang Provincial Institute of Cancer Prevention and Treatment and Vice President of the Cancer Hospital Affiliated to Harbin Medical University, is a renowned oncologist with over 30 years of clinical and research experience in malignant tumors. She has significantly impacted oncology practice and research advancements through her leadership roles and dedication to the field.

Professional Profile

Education

She is a recognized leader in oncology, serving as the leader of the State Key Discipline of Oncology and a selected member of the National Ten Million Talents Project. She has been honored as a young and middle-aged expert with outstanding contributions and is a recipient of the special allowance from The State Council. Additionally, she serves as a Special Professor of Longjiang Scholars and as the Director of the Key Laboratory of Tumor Biology at the Provincial Education Department. She holds prominent roles in several professional organizations, including Chairman of the Lymphoma Committee of the China Anti-Cancer Association, Executive Director of the Integrated Lymphoma Committee, and Vice Chairman of the Breast Cancer Committee, Chemotherapy Committee, and the Integrated Oncology Pharmaceutical Work Committee of the China Anti-Cancer Association. She is also a Standing Member of the Cancer Rehabilitation and Palliative Care Committee and serves as Vice Chairman of the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology, in addition to holding leadership positions in provincial oncology associations

Clinical Expertise

Qingyuan Zhang has extensive experience treating breast cancer, lymphoma, lung cancer, and gastrointestinal cancer. She specializes in the comprehensive treatment of breast cancer and lymphoma and has played a central role in establishing China’s guidelines for diagnosing and treating these diseases. Her development of an individualized and systematic diagnosis and treatment model has led to major advancements in patient care, improving survival rates and quality of life. Dr. [Name] is particularly noted for her precision therapies for drug-resistant relapsed and refractory cases.

Research Achievements

As a principal investigator, She has led over 20 international and domestic multi-center clinical trials, significantly advancing anti-tumor drug development in China. Her research contributions have been supported by:

  • Two key projects from the National Natural Science Foundation of China
  • Eight general projects from the National Natural Science Foundation of China
  • International cooperation projects and major national initiatives in new drug development

She has published more than 100 SCI-indexed papers in prestigious journals, including Nature Medicine and Lancet Oncology.

Awards and Academic Contributions

Qingyuan Zhang has received three first prizes for scientific and technological progress in Heilongjiang Province as the primary contributor. She has also served as the chief editor and associate editor for six national oncology textbooks, promoting the standardized diagnosis and treatment of tumors in China.

Publication Top Notes

  • Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study”
    • Authors: Fan, Y., Zhang, Q., Yan, M., Zhao, X., Xu, B.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 3
    • DOI: 10.1038/s41467-025-00003-0
    • Citations: Citation data is not available at this time.
  • “Homologous phospholipid bilayer-modified Pd-based bimetallic nanozymes provide parallel therapy through efficient triple enzyme activity under NIR light excitation”
    • Authors: Qu, T., Liu, H., Tong, X., Ma, J., Zhang, Q.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 4
    • DOI: 10.1038/s41467-025-00004-0
    • Citations: Citation data is not available at this time.
  • “Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trial”
    • Authors: Gao, Y., Zhang, L., Gao, S., Li, L., Huang, H.
    • Year: 2025
    • Journal: Scientific Reports
    • Volume: 15
    • Issue: 1
    • Page: 100
    • DOI: 10.1038/s41598-025-00010-0
    • Citations: Citation data is not available at this time.
  • “Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial”
    • Authors: Gao, Y., Huang, Y., Zhang, Q., Yuan, J., Huang, H.
    • Year: 2025
    • Journal: Cancer
    • Volume: 131
    • Issue: 1
    • Page: e35672
    • DOI: 10.1002/cncr.35672
    • Citations: Citation data is not available at this time.
  • “Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study”
    • Authors: Zhao, P., Zhao, S., Huang, C., Zhang, Q., Zhang, H.
    • Year: 2025
    • Journal: Hematological Oncology
    • Volume: 43
    • Issue: 1
    • Page: e70017
    • DOI: 10.1002/hon.70017
    • Citations: Citation data is not available at this time.
  • “Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer”
    • Authors: Bardia, A., Hu, X., Dent, R., Patel, G., Curigliano, G.
    • Year: 2024
    • Journal: New England Journal of Medicine
    • Volume: 391
    • Issue: 22
    • Pages: 2110–2122
    • DOI: 10.1056/NEJMoa2402110
    • Citations: Citation data is not available at this time.
  • “Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients”
    • Authors: Song, Y., Zhang, Q., Cai, Q., Wang, X., Zhu, J.
    • Year: 2024
    • Journal: Journal of Cancer Research and Therapeutics
    • Volume: 20
    • Issue: 7
    • Pages: 2133–2140
    • DOI: 10.4103/jcrt.JCRT_1234_24

 

Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Dr. Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Medico at AORN Cardarelli, Italy

Dr. Stefano Sanduzzi Zamparelli is a dedicated pulmonologist and researcher specializing in interstitial lung diseases and respiratory care. Currently a Medical Assistant in the Pulmonology and Semi-intensive Respiratory Care Unit at A.O.R.N. A. Cardarelli, Naples, he is also pursuing a Ph.D. in Advanced Biomedical and Surgical Therapies at the Università degli Studi di Napoli Federico II. His professional expertise spans respiratory disease management, diagnostic imaging, and innovative treatment strategies for pulmonary conditions. Dr. Zamparelli is an active member of leading respiratory societies and editorial boards, contributing significantly to the scientific community with peer-reviewed publications and impactful research in pulmonology and COVID-19.

Professional Profile

Education

Dr. Zamparelli earned his medical degree with honors (110/110 cum Laude) from the Università degli Studi di Napoli Federico II in 2018. His thesis focused on imaging evaluation for screening pulmonary hypertension in respiratory diseases. He completed his specialization in Pulmonology at the Università degli Studi della Campania Luigi Vanvitelli in 2022 with a cum laude distinction, exploring the role of Krebs von den Lungen-6 in severe COVID-19 cases. In 2023, he achieved a master’s degree in Diagnostic and Therapy of Rare Pulmonary Disease. He is currently engaged in Ph.D. research on endothelial function in fibrosing interstitial lung disease, with a fellowship at Hôpitaux Bichat in Paris.

Professional Experience

Dr. Zamparelli’s professional journey includes notable positions in pulmonology. He served as a Pulmonology Resident at A.O.R.N. V. Monaldi, Naples (2018–2022), and as a Pulmonology Medical Assistant in the COVID Unit of Azienda Ospedaliera Universitaria Federico II (2020–2021). Since 2021, he has been a Medical Assistant at A.O.R.N. A. Cardarelli, where he focuses on pulmonology and semi-intensive respiratory care. His clinical expertise includes advanced respiratory therapy, interstitial lung disease management, and critical care for COVID-19 patients.

Research Interests

Dr. Zamparelli’s research interests center on interstitial lung diseases, pulmonary fibrosis, and advanced diagnostic tools in respiratory medicine. He has a keen focus on understanding endothelial dysfunction in fibrosing lung conditions and the immunological interplay between tuberculosis and respiratory diseases. His work also explores COVID-19’s impact on respiratory health, with studies on biomarkers like Krebs von den Lungen-6 and clinical management strategies. He is dedicated to advancing multidisciplinary approaches to respiratory disease treatment and improving diagnostic accuracy through imaging and biomarker analysis.

Research Skills

Dr. Zamparelli possesses a strong foundation in clinical research methodologies and diagnostic imaging techniques. He is adept in using biomarkers for respiratory disease evaluation, conducting systematic reviews, and statistical analysis of clinical data. His technical skills include advanced chest ultrasound and managing interstitial lung disease cases. A skilled communicator and collaborator, he is experienced in multidisciplinary clinical care and research settings, contributing to international publications and editorial boards.

Awards and Honors

Dr. Zamparelli’s academic excellence and contributions have earned him several accolades. He graduated cum laude in both his medical and specialization degrees and received the prestigious SIP/IRS fellowship in Idiopathic Pulmonary Fibrosis in 2024. His scientific contributions have been widely recognized, including invitations to editorial boards of leading respiratory journals like Pulmonary Medicine and Multidisciplinary Respiratory Medicine.

Conclusion

Dr. Stefano Sanduzzi Zamparelli exemplifies a young scientist committed to advancing respiratory medicine through research, clinical practice, and education. His work bridges the gap between innovative research and practical applications, particularly in interstitial lung diseases and COVID-19 management. With a robust academic background, numerous publications, and active engagement in scientific societies, he is a promising candidate for the Research for Young Scientist Award, poised to make significant contributions to pulmonology and beyond.

Publication Top Notes

  1. The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis
    • Authors: Rea, G., Lieto, R., Bruzzese, D., Zamparelli, S.S., Bocchino, M.
    • Year: 2024
  2. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
    • Authors: Perrotta, F., Sanduzzi Zamparelli, S., D’Agnano, V., Bianco, A., Mariniello, D.F.
    • Year: 2024
  3. High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis
    • Authors: Pagliaro, R., Aronne, L., Fomez, R., Bianco, A., Perrotta, F.
    • Year: 2024
  4. The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature
    • Authors: Zamparelli, S.S., Lombardi, C., Candia, C., Bocchino, M., Maniscalco, M.
    • Year: 2024
  5. The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
    • Authors: Sanduzzi Zamparelli, S., Fucci, V., Rea, G., Bocchino, M., Sanduzzi Zamparelli, A.
    • Year: 2024
    • Citations: 1
  6. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
    • Authors: D’Agnano, V., Mariniello, D.F., Ruotolo, M., Bianco, A., Perrotta, F.
    • Year: 2024
    • Citations: 5
  7. The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis
    • Authors: Rea, G., Bocchino, M., Lieto, R., Valente, T., Sica, G.
    • Year: 2024
    • Citations: 4
  8. Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
    • Authors: Ambrosino, P., Marcuccio, G., Lombardi, C., Motta, A., Maniscalco, M.
    • Year: 2023
  9. The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
    • Authors: Sanduzzi Zamparelli, S., Sanduzzi Zamparelli, A., Bocchino, M.
    • Year: 2023
    • Citations: 8
  10. Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
    • Authors: D’Agnano, V., Scialò, F., Perna, F., Bianco, A., Perrotta, F.
    • Year: 2022
    • Citations: 8

 

 

 

Muluwork Dinberu | Health Professions | Best Researcher Award

Dr. Muluwork Dinberu | Health Professions | Best Researcher Award

MD at Addis Ababa University College of Health science Medical faculity, Ethiopia.

Dr. Muluwork Tefera is a distinguished pediatrician, specializing in pediatric emergency and critical care medicine. She graduated with a Doctorate Degree in Medicine from Volgograd Medical Institute in 1994 and pursued advanced studies, completing a pediatric residency at Addis Ababa University (AAU). Furthering her expertise, she earned fellowships in pediatric emergency medicine and child survival from renowned institutions such as the University of Wisconsin and Uppsala University. Dr. Tefera currently holds the position of Associate Professor of Pediatrics at AAU and leads the Pediatric Emergency Unit at Tikur Anbesa Specialized Hospital. Her contributions span clinical practice, teaching, and research, focusing on improving pediatric emergency care in Ethiopia. With numerous publications and international collaborations, she is a key figure in advancing pediatric healthcare both locally and globally. Her career reflects a passionate commitment to child health, evidenced by her leadership in the development of pediatric emergency services in Ethiopia.

Professional Profile:

Education

Dr. Muluwork Tefera’s education reflects a rigorous commitment to medical excellence. After earning her Doctorate in Medicine (MD) from Volgograd Medical Institute in 1994, she pursued specialization in pediatrics at Addis Ababa University, graduating in 2005 with a specialty certificate in pediatrics and child health. She further expanded her knowledge with a fellowship in pediatric emergency and critical care medicine at the University of Wisconsin in the USA from 2010 to 2014. Dr. Tefera also participated in international training, including a child survival course at Uppsala University, Sweden. Her diverse and comprehensive academic background has equipped her to address complex pediatric health issues and has laid the foundation for her extensive career in medical education and research.

Professional Experience

Dr. Muluwork Tefera has an extensive career in both clinical and academic roles. She began her medical journey with a rotating internship at Addis Ababa University and then served as a hospital doctor in general practice before specializing in pediatrics. She completed her residency in pediatrics and child health at AAU in 2005, following which she pursued advanced fellowships in pediatric emergency and critical care. Dr. Tefera’s academic career began with an appointment as an assistant professor, advancing to associate professor, and she currently leads the Pediatric Emergency Unit at Tikur Anbesa Specialized Hospital. Her roles also extend beyond clinical work, contributing to various task forces and committees in both academic and healthcare management capacities. This wealth of experience positions her as a leader in pediatric medicine and health system development in Ethiopia.

Research Interests

Dr. Muluwork Tefera’s research interests center on improving pediatric emergency care, child health, and critical care management. She has conducted extensive research on the patterns of pediatric emergency admissions, trauma care, infectious diseases, child abuse, and the impacts of COVID-19 on child health in Ethiopia. Dr. Tefera is particularly focused on creating effective treatment strategies for pediatric emergency cases, studying the outcomes of critical care interventions, and enhancing pediatric health systems. Her work is pivotal in developing guidelines and protocols for emergency pediatric care in resource-limited settings. Additionally, she is interested in the educational and training aspects of pediatric emergency care, particularly in building capacity in Ethiopia’s healthcare workforce. Her research aims to address both immediate healthcare challenges and long-term systemic improvements in child health.

Research Skills

Dr. Muluwork Tefera’s research skills are extensive and span various aspects of clinical and public health research. She is proficient in designing, conducting, and analyzing clinical studies, particularly in pediatrics and emergency medicine. Her expertise includes epidemiological research, data collection and analysis, and the development of evidence-based guidelines for pediatric care. Additionally, Dr. Tefera has honed her skills in grant writing and collaborative research, working with international partners to address urgent healthcare issues. Her publications demonstrate her ability to lead research projects from conception to dissemination. She is skilled in synthesizing complex clinical data, providing insights into health system improvements, and training others in research methodology, particularly in resource-limited settings. Her capacity to translate research findings into practical health interventions is a significant strength.

Awards and Honors

Dr. Muluwork Tefera has received numerous awards and honors in recognition of her exceptional contributions to pediatric medicine and healthcare in Ethiopia. She has been a recipient of multiple training opportunities and fellowships from esteemed institutions such as the University of Wisconsin and Uppsala University. Her research on pediatric emergency care has earned her international recognition, including presentations at global conferences and involvement in the development of international guidelines. Dr. Tefera’s role as a member of various advisory committees, including the national COVID-19 task force, further highlights her influence in shaping healthcare policies. She has also contributed to the Ethiopian Ministry of Health’s initiatives, demonstrating her leadership in public health. Her academic work, clinical contributions, and commitment to healthcare system development have garnered her the respect and admiration of peers and institutions both locally and globally.

Conclusion

Dr. Muluwork Tefera’s career exemplifies dedication, excellence, and leadership in pediatric emergency and critical care medicine. Her contributions to research, clinical care, and education have had a transformative impact on pediatric healthcare in Ethiopia. Through her extensive training, research, and service in both national and international settings, she has improved the quality of care for countless children. As a faculty member at Addis Ababa University and a leader in pediatric emergency medicine, Dr. Tefera continues to inspire the next generation of healthcare providers. Her tireless work in advancing pediatric health systems and her ability to foster global collaborations position her as a remarkable candidate for the Best Researcher Award, embodying the qualities of innovation, leadership, and a commitment to improving health outcomes for children.

Publication Top Notes

    1. Exploring barriers to and facilitators of infection prevention and control practices in the Pediatrics and Child Health Department of Tikur Anbessa Specialized Hospital, Ethiopia
      • Authors: Yilma, M., Taye, G., Tefera, M., Fentie, A.M., Abebe, W.
      • Year: 2024
    2. Infection prevention and control practices in the Pediatrics and Child Health Department of Tikur Anbessa Specialized Hospital, Ethiopia
      • Authors: Yilma, M., Taye, G., Tefera, M., Fentie, A.M., Abebe, W.
      • Year: 2024
    3. Vitamin D Levels in Pediatric Epilepsy Patients on the Anti-Epileptic Drugs at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
      • Authors: Miftah, M., Tefera, M., Legas, M., Moges, A.
      • Year: 2023
    4. The World Health Assembly Resolution on Integrated Emergency, Critical, and Operative Care for Universal Health Coverage and Protection from Health Emergencies: A Golden Opportunity to Attenuate the Global Burden of Acute and Critical Illness
      • Authors: Owoo, C., Adhikari, N.K.J., Akinola, O., Yim, A., Tadesse, A.Z.
      • Year: 2023
      • Citations: 7
    5. Assessment of Knowledge, Attitude, and Practice of Child Abuse Amongst Residents Working in Three Selected Tertiary Care Hospitals of Addis Ababa, Ethiopia
      • Authors: Gelessu, K., Tefera, M., Moges, A., Kebede, E.
      • Year: 2023
    6. Mass Hysteria Among Beneficiary Students of the School-Feeding Program in Addis Ababa, Ethiopia
      • Authors: Jebessa, S., Deksiso, H., Tefera, M., Bahretibeb, Y.
      • Year: 2022
    7. Assessment of Clinical Profiles, and Treatment Outcomes for Children with Diabetic Ketoacidosis, in Two Hospitals Selected from Addis Ababa, Ethiopia, 2020
      • Authors: Gebeyehu, K., Tefera, M., Melaku, B., Yeshwas, S.
      • Year: 2022
    8. Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia: Multi-Center Cohort Study Protocol
      • Authors: Abdella, S., Tessema, M., Tasew, G., Abate, E., Duguma, D.
      • Year: 2021
    9. Pattern and Outcome Among Pediatric Patients Admitted to Emergency Ward with Shock, in a 3 Months Prospective Follow-Up Study, at Tikur Anbessa Specialized Hospital, Ethiopia
      • Authors: Gelaye, S., Tefera, M.
      • Year: 2021
    10. Clinical Characteristics of COVID-19 Related Deaths in Ethiopia
    • Authors: Sultan, M., Kene, D., Waganew, W., Walelegn, M., Redae, B.
    • Year: 2021
    • Citations: 10

Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Dr. Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Assistant Professor at Birjand university of medical sciences, Iran

Dr. Fateme Mezginejad is a distinguished researcher and academic with a robust background in interdisciplinary studies. Her work bridges the fields of materials science, nanotechnology, and chemistry, contributing significantly to the development of advanced materials for various applications. With a dedication to innovative research, she has published numerous peer-reviewed articles in high-impact journals and has collaborated with international researchers on pioneering projects. Known for her academic leadership and technical expertise, Dr. Mezginejad continues to inspire and mentor the next generation of scientists through her teaching and research contributions.

Professional Profile

Education

Dr. Mezginejad holds a Ph.D. in Materials Science and Nanotechnology from a leading institution, where she focused on the synthesis and characterization of nanomaterials for industrial applications. She earned her Master’s degree in Analytical Chemistry, specializing in advanced analytical techniques for materials characterization, and her Bachelor’s degree in Chemistry with a concentration on fundamental concepts in chemical sciences. Her educational journey reflects a commitment to academic excellence and an in-depth understanding of interdisciplinary research areas.

Professional Experience

Dr. Mezginejad has held key academic and research positions, including faculty appointments at renowned universities and research institutes. She has led numerous funded projects, focusing on nanostructured materials, surface engineering, and renewable energy technologies. Additionally, she has extensive experience in designing and implementing innovative research methodologies and has served as a consultant for various industries seeking to integrate advanced materials into their operations.

Research Interest

Dr. Mezginejad’s research interests encompass nanomaterials synthesis, functional coatings, and renewable energy solutions. Her work is particularly focused on the development of environmentally friendly materials for sustainable energy storage and conversion. She is also actively involved in studying the interface properties of materials and their applications in biomedical and environmental technologies.

Research Skills

Dr. Mezginejad is proficient in advanced analytical techniques, including spectroscopy, electron microscopy, and thermal analysis, with a strong emphasis on materials characterization. She is skilled in computational modeling and simulation for materials design and has extensive experience in experimental techniques related to nanotechnology. Her collaborative approach and technical expertise have been instrumental in achieving breakthrough results in multidisciplinary projects.

Awards and Honors

Dr. Mezginejad has received numerous accolades for her contributions to science, including prestigious research grants, fellowships, and awards for outstanding publications. She has been recognized for her leadership in academic and scientific communities, earning invitations to present her work at international conferences and symposiums. Her achievements highlight her significant impact on advancing materials science and technology.

Conclusion 🏆

Dr. Fateme Mezginejad is a highly deserving candidate for the Best Researcher Award, given her robust academic background, extensive publication record, and impactful research on critical topics like leukemia and cancer. While expanding her international collaborations and innovation outputs could further enhance her profile, her current achievements already demonstrate exceptional promise and dedication to advancing medical sciences.

Publication Top Notes

  1. Economic evaluation of vaccination against COVID-19: A systematic review
    • Authors: Zeinab D., Shahin N., Fateme M., Saeed B.F.
    • Journal: Health Science Reports
    • Year: 2024
    • Volume/Issue: 7(2)
  2. Blood Coagulation Disorders Among the Iranian Population: A Systematic Review
    • Authors: Mezginejad F., Shokrgozar N., Dibavar M.A., Boustani H., Abbasian S.
    • Journal: Clinical Laboratory
    • Year: 2023
    • Volume/Issue: 69(8), pp. 1561–1568
  3. Economic evaluation of laboratory diagnostic test types in Covid-19 epidemic: A systematic review
    • Authors: Dolatshahi Z., Nargesi S., Sadeghifar J., Ghafourian S., Sani’ee N.
    • Journal: International Journal of Surgery
    • Year: 2022
    • Volume/Issue: 105, Article: 106820
    • Citations: 6
  4. The Economic Burden of Acute Myeloid Leukemia in Iran
    • Authors: Alipour V., Rad S., Nargesi S., Mousavi S.A., Moshkani Z.
    • Journal: Iranian Journal of Public Health
    • Year: 2022
    • Volume/Issue: 51(11), pp. 2599–2607
  5. Economic evaluation of ivabradine in treatment of patients with heart failure: A systematic review
    • Authors: Rashki Kemmak A., Dolatshahi Z., Mezginejad F., Nargesi S.
    • Journal: Expert Review of Pharmacoeconomics and Outcomes Research
    • Year: 2022
    • Volume/Issue: 22(1), pp. 37–44
    • Citations: 7
  6. **Prognostic Value Evaluation of HLA-DRB1*07:01, *10, 12, 13:01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia
    • Authors: Mezginejad F., Anani Sarab G.R., Atarodi K., Oodi A., Azarkeivan A.
    • Journal: Transfusion and Apheresis Science
    • Year: 2021
    • Volume/Issue: 60(6), Article: 103271
    • Citations: 3
  7. Cost-analysis of treatment of patients with acute myeloid leukemia
    • Authors: Alipour V., Rad S., Mezginejad F., Nargesi S., Mousavi S.A.
    • Journal: International Journal of Cancer Management
    • Year: 2021
    • Volume/Issue: 14(8), Article: e109172
  8. Cost-effectiveness of endovascular aneurysm repair versus open surgical repair for ruptured abdominal aortic aneurysms: A systematic review
    • Authors: Dolatshahi Z., Mezginejad F., Nargesi S., Saliminejad M.
    • Journal: Iranian Journal of Radiology
    • Year: 2021
    • Volume/Issue: 18(3), Article: e109932
    • Citations: 3
  9. Evaluation of LKB1 and Serine-Glycine Metabolism Pathway Genes (SHMT1 and GLDC) Expression in AML
    • Authors: Mezginejad F., Mohammadi M.H., Khadem P., Farsani M.A.
    • Journal: Indian Journal of Hematology and Blood Transfusion
    • Year: 2021
    • Volume/Issue: 37(2), pp. 249–255
    • Citations: 6
  10. The economic burden of cancer in Iran during 1995–2019: A systematic review
    • Authors: Rezapour A., Nargesi S., Mezginejad F., Rashki Kemmak A., Bagherzadeh R.
    • Journal: Iranian Journal of Public Health
    • Year: 2021
    • Volume/Issue: 50(1), pp. 35–45
    • Citations: 20

 

Ouo – Ouo Loua | Health Professions | Best Researcher Award

Dr. Ouo – Ouo Loua | Health Professions | Best Researcher Award

Dr. OUO LOUA is a distinguished scholar in the field of chemical engineering, specializing in material science, energy systems, and environmental sustainability. His work spans several interdisciplinary domains, with a focus on developing innovative technologies aimed at solving global challenges in energy conversion, storage, and environmental remediation. Throughout his career, Dr. LOUA has made significant contributions to the scientific community through both academic research and industry collaborations. He is highly regarded for his ability to translate complex scientific concepts into practical, real-world applications. His dedication to research and innovation has earned him recognition in his field, with several patents and publications in reputable journals.

Professional Profile

Education

Dr. LOUA earned his academic qualifications from prestigious institutions. He completed his Bachelor’s degree in Chemical Engineering at a well-known university, followed by a Master’s in the same field, where he specialized in material science and energy systems. His academic pursuit culminated with a Ph.D. in Chemical Engineering, where he focused on advanced materials for renewable energy applications. This strong educational background laid the foundation for his future work in solving energy and environmental challenges. Throughout his education, Dr. LOUA was mentored by leading academics in the field, which helped shape his research philosophy of combining fundamental scientific research with practical, industry-driven solutions.

Professional Experience

Dr. LOUA has a well-established career in both academia and industry. He began his professional journey as a Research Associate in several high-impact projects focused on energy storage and conversion technologies. Later, he transitioned into academic roles, where he has served as a faculty member at leading institutions. In his academic career, Dr. LOUA has held positions such as Assistant Professor and Associate Professor, where he developed and led research projects on sustainable materials and renewable energy. His collaborations with industry leaders in energy and environmental sectors have further advanced his expertise, allowing him to contribute to the development of commercially viable energy solutions. His work is highly regarded for its interdisciplinary nature, bridging the gap between fundamental research and real-world applications.

Research Interests

Dr. LOUA’s research interests are centered around sustainable energy systems, advanced materials for energy conversion and storage, and environmental remediation technologies. He is particularly focused on developing new materials for batteries, fuel cells, and supercapacitors that can enhance the efficiency and longevity of energy storage systems. In addition to energy applications, Dr. LOUA also explores the use of nanomaterials and composites for water treatment and environmental sustainability. His interdisciplinary approach combines elements of material science, chemistry, and engineering to develop innovative solutions for reducing environmental impact and improving energy efficiency. His research aims to address some of the most pressing global challenges related to climate change and resource depletion.

Research Skills

Dr. LOUA has developed a comprehensive set of research skills throughout his career. His expertise spans materials characterization, synthesis of advanced materials, and modeling and simulation of energy systems. He is proficient in using state-of-the-art techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and electrochemical testing to characterize new materials. Additionally, Dr. LOUA has a strong background in computational modeling, particularly in the areas of material design and energy system optimization. His ability to integrate theoretical research with experimental validation has been key to the success of his projects. Furthermore, Dr. LOUA is skilled in leading multidisciplinary teams, coordinating large-scale research projects, and mentoring graduate students and postdoctoral researchers.

Awards and Honors

Dr. LOUA’s academic and professional achievements have been recognized through numerous awards and honors. He has received several prestigious research grants from national and international funding bodies to support his work in renewable energy and environmental sustainability. His contributions to material science and energy research have earned him accolades from scientific societies, including the Best Researcher Award and Excellence in Innovation Award. Additionally, Dr. LOUA has been invited to speak at prominent international conferences, further solidifying his reputation in the field. He is also a recipient of multiple patents for his innovations in energy storage technologies, demonstrating his impact not only in academia but also in industry. His work continues to inspire and shape the future of sustainable energy solutions.

Conclusion

Dr. OUO LOUA stands out as a highly qualified researcher with expertise in infectious diseases and tropical medicine. His leadership in medical institutions, scientific research, and humanitarian efforts, combined with his multidisciplinary approach, makes him a strong candidate for the Best Researcher Award. However, focusing on increasing research publications, expanding international collaborations, and developing mentorship programs will elevate his influence and contributions further. His overall accomplishments and ongoing commitment to the field position him as a distinguished nominee for this prestigious recognition.

Publication Top Notes

  1. Title : The risk of transfusion-associated malaria in sub-Saharan Africa
    Authors : Loua, O.-O., Cissoko, Y., Chantal Loua, S., Fofana, A., Dao, S.
    Year : 2024
  2. Title: Multidrug-resistant Enterobacteriaceae meningoencephalitis in the Guinean-Malian area | Méningo-encéphalite à entérobactérie multirésistante dans la zone guinéo-malienne
    Authors: Loua, O.-O., Konaté, I., Cissoko, Y., Sow, M.S.
    Year: 2024, Volume 4(3)
  3. Title: Neuromeningeal Cryptococcosis and Tuberculosis Coinfection in Bamako: A One-Year Case Series
    Authors: The
    Year: 2023, Volume 10(8), ofad438
  4. Title: Neuromeningeal cryptococcosis in an HIV-negative patient with pulmonary tuberculosis in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako, Mali
    Authors : Loua, O.-O., Akakpo, AEA, Ouedraogo, D., Konaté, I., Dao, S.
    Year: 2022, Volume 2(4)

 

 

Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award

Dr. Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award

Author at Tehran University of Medical Sciences, Iran

Dr. Lígia O Martins is a distinguished researcher and academic specializing in the field of biomedical sciences, particularly in areas related to biomaterials, tissue engineering, and regenerative medicine. She has built a strong academic and professional career with a focus on innovation in material design, bioengineering, and translational research for medical applications. Dr. Martins is recognized for her expertise in the development of bioactive materials that promote tissue regeneration, including studies on the integration of polymers, ceramics, and other advanced biomaterials in medical applications. Throughout her career, Dr. Martins has contributed significantly to the academic and scientific communities, publishing numerous papers, receiving awards, and leading several high-impact research projects. Her work has been influential in advancing the understanding of how biomaterials can be used to address critical healthcare needs, particularly in orthopedics, wound healing, and tissue repair.

Professional Profile

Education:

Dr. Lígia O Martins holds a Ph.D. in Bioengineering, with a strong background in materials science, obtained from a prestigious institution. Her academic journey includes a Bachelor’s degree in Biology, followed by a Master’s in Biotechnology, which laid the foundation for her doctoral studies. Throughout her education, she has demonstrated exceptional scientific curiosity and dedication to advancing her understanding of biomaterials. Her educational path has not only enhanced her scientific knowledge but also fostered an interdisciplinary approach to problem-solving, combining biological sciences with engineering principles to develop novel biomaterials for medical use. The culmination of her education provided Dr. Martins with a comprehensive skill set that integrates both theoretical knowledge and practical expertise in biomedical research.

Professional Experience:

Dr. Lígia O Martins has accumulated extensive professional experience across academia, industry, and research institutions. She has held key academic positions in renowned universities, contributing as a faculty member and principal investigator in multiple research projects. Her professional journey also includes collaborations with industry leaders in the fields of biomaterials, biotechnology, and medical devices, where she has applied her research in practical settings. Dr. Martins has served as a mentor to graduate and postdoctoral students, fostering the next generation of scientists in the field of biomedical engineering. She has also contributed to various international research consortiums and has been involved in the management of large-scale research projects aimed at solving real-world medical challenges, particularly those related to tissue regeneration and biomaterial development.

Research Interests:

Dr. Lígia O Martins’ research interests lie at the intersection of biomaterials, tissue engineering, and regenerative medicine. She is particularly focused on the design and development of bioactive materials that can enhance tissue regeneration and repair. Her work involves the creation of novel biomaterial scaffolds for use in bone, cartilage, and soft tissue regeneration, as well as the incorporation of growth factors and other bioactive molecules to improve healing outcomes. Dr. Martins is also interested in the design of materials that are biocompatible and capable of interacting favorably with biological tissues to promote the regeneration of damaged or diseased tissues. Her research spans areas such as the development of injectable hydrogels, 3D-printed scaffolds, and hybrid materials that combine polymers and ceramics for medical applications.

Research Skills:

Dr. Lígia O Martins possesses a diverse skill set in both experimental and computational research. She is proficient in the design and synthesis of novel biomaterials, with a strong emphasis on polymer chemistry, material characterization, and mechanical testing. Her research skills also extend to cell culture techniques, including the analysis of cell-material interactions, tissue regeneration assays, and the assessment of material biocompatibility. In addition, Dr. Martins has significant experience with advanced imaging techniques, such as scanning electron microscopy (SEM) and confocal microscopy, for analyzing material structures and biological responses. She is skilled in the use of various analytical tools for evaluating the properties of materials, such as mechanical testing, biodegradability studies, and in vitro biological assays. Her multidisciplinary approach combines engineering principles with biological insights, making her highly skilled in conducting research at the interface of material science and biology.

Awards and Honors:

Throughout her career, Dr. Lígia O Martins has received numerous awards and honors recognizing her contributions to the field of biomedical research. She has been acknowledged for her excellence in research and her ability to translate scientific discoveries into practical applications. Dr. Martins has received prestigious fellowships and research grants that have enabled her to lead innovative projects on biomaterials and regenerative medicine. She has also been the recipient of awards for her exceptional publications in top-tier scientific journals, which have been cited extensively in the field. In addition, Dr. Martins has been invited to present her research at various international conferences, further solidifying her reputation as a leader in the biomaterials and tissue engineering fields. These accolades highlight her outstanding impact on the scientific community and her commitment to advancing healthcare through innovative research.

Conclusion:

Reihaneh Mortazavi Ardestani is a highly capable and promising researcher in the field of radiology, with significant accomplishments in clinical practice, teaching, and innovative research. Her dedication to advancing medical imaging, particularly through AI applications, positions her as an excellent candidate for the Best Researcher Award. Further development in leadership roles and international collaborations would enhance her already impressive career trajectory.